Table 5.
Stage | Site | Primary tumoura | Sizeb | Regional nodesc | Distant metastasisd |
---|---|---|---|---|---|
I | Orbit | T1 or T2 | a or b | N0, N1 or NX | M0 |
Head and neck (excluding parameningeal) | |||||
Genitourinary, nonbladder nonprostate | |||||
II | Bladder and prostate | T1 or T2 | a | N0 or NX | M0 |
Extremity | |||||
Cranial parameningeal | |||||
Other (including trunk, retroperitoneum, etc) | |||||
III | Bladder and prostate | T1 or T2 | a | N1 | M0 |
Extremity | |||||
Cranial parameningeal | T1 or T2 | b | N0, N1 or NX | M0 | |
Other (including trunk, retroperitoneum, etc) | |||||
IV | All sites | T1 or T2 | a or b | N0 or N1 | M1 |
aT1 tumour limited to original muscle or organ, T2 tumour has extension or fixation to the surrounding tissue.
ba tumour equal to or less then 5 cm in greatest dimension, b tumour larger than 5 cm in greatest dimension.
cN0 no clinical involvement of regional nodes, N1 clinical involvement of regional nodes, NX status of regional nodes unknown.
dM0 no distant metastasis, M1 distant metastasis.